Overview
- The Karolinska Institute in early October 2026 awarded the Nobel Prize in Physiology or Medicine to Karl Deisseroth, Peter Hegemann, and Georg Nagel for work that enabled optogenetics.
- Hegemann traced light sensitivity to proteins in the alga Chlamydomonas, Nagel showed those genes encode light-gated ion channels called channelrhodopsins, and Deisseroth introduced ChR2 into mammalian neurons to trigger spikes with blue light.
- Recent coverage highlights additional contributors omitted from the prize, including Suneel Kateriya, who was an author on early 2002–2003 papers that identified the Chlamydomonas sequences later linked to channelrhodopsins.
- Optogenetics gives researchers millisecond control over specific cell types, has reshaped studies of memory, emotion and behavior, and is being tested in early clinical efforts such as experimental retinal therapies that pair light-sensitive proteins with external devices.
- The prize underscores a multi-disciplinary, stepwise discovery process and raises questions about how credit is allocated in big-team science while signaling that next steps will focus on careful clinical translation and broader adoption of the optogenetic toolkit.